Triamterene And Hydrochlorothiazide
Product Images NDC 70934-143

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Triamterene And Hydrochlorothiazide (NDC 70934-143). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (70934 143 30 Rev A 08 19)

Label (70934 143 30   Rev A 08 19)
This text contains information on a medication with NDC 70934-143.30. The medication is a combination of Triamterene and Hydrochlorothiazide, and comes in tablet form in the USP. There is no further information available.*
FDA Label Image

Structure-hydrochlorothiazide (Structure Hydrochlorothiazide)

Structure-hydrochlorothiazide (Structure Hydrochlorothiazide)
This is a description of a chemical compound with the CHCIN:O,S molecular formula and a molecular weight of 297.73. No further information is available.*
FDA Label Image

Structure-triamterene (Structure Triamterene)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.